Guerbet Vendor's profile
A pioneer in the field of contrast agent with nearly 90 years’ experience
Guerbet is a pioneer in the contrast agent field, with nearly 90 years’ experience, and is the only pharmaceutical group dedicated to medical imaging worldwide. It offers a comprehensive range of XRay, Magnetic Resonance Imaging (MRI) and Interventional Radiology and Theranostics (IRT) products, along with a range of injectors and related medical devices to improve the diagnosis and treatment of patients. To discover new products and ensure future growth, Guerbet invests heavily in R&D, spending around 9% of its sales each year. Guerbet (GBT) is listed on NYSE Euronext Paris (Segment B – Mid Caps) and generated revenue of €409 million in 2014. It had a total workforce of 1,461 employees at 31 December 2014.
Follow Guerbet on the web and social networks:
To feature here : Get in touch
Olea Medical® case report on early & late MR diffusion follow-up of a stroke using CT perfusion.
Olea Medical® literature meta-analysis on CTP thresholds in acute stroke
Ziehm Vision RFD Hybrid Edition: Mobility and flexibility – the difference in an emergency
Agfa HealthCare Special Report Dose Management: because life is precious.